HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M T Rossi Selected Research

Clostridium perfringens delta-toxin (CPDT)

6/2022A randomized split-face clinical trial of conventional vs indoor-daylight photodynamic therapy for the treatment of multiple actinic keratosis of the face and scalp and photoaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M T Rossi Research Topics

Disease

4Actinic Keratosis
06/2022 - 05/2014
2Psoriasis (Pustulosis Palmaris et Plantaris)
07/2013 - 06/2012
1Inflammation (Inflammations)
06/2022
1Urticaria (Hives)
06/2012
1Pruritus (Itching)
08/2011
1Carcinoma (Carcinomatosis)
03/2009
1Rectal Neoplasms (Rectal Cancer)
06/2008

Drug/Important Bio-Agent (IBA)

21-phenyl-3,3-dimethyltriazene (PDT)IBA
06/2020 - 05/2014
2Diclofenac (SR 38)FDA LinkGeneric
06/2020 - 05/2014
2Etanercept (Enbrel)FDA Link
07/2013 - 06/2012
1Clostridium perfringens delta-toxin (CPDT)IBA
06/2022
13-ingenyl angelateIBA
06/2020
1methyl 5-aminolevulinateIBA
05/2014
1Hyaluronic Acid (Hyaluronan)IBA
05/2014
11 alpha,24-dihydroxyvitamin D3 (Tacalcitol)IBA
08/2011
1Ointments (Pastes)IBA
08/2011
1Budesonide (Pulmicort)FDA LinkGeneric
08/2011

Therapy/Procedure

2Photochemotherapy (Photodynamic Therapy)
06/2022 - 05/2014
1Gas Lasers
05/2014
1Cryotherapy (Therapy, Cold)
05/2014
1Phototherapy (Light Therapy)
07/2013
1Therapeutics
07/2013
1Drug Therapy (Chemotherapy)
03/2009
1Neoadjuvant Therapy
06/2008